What is Patient Listening and How Does it Work in Clinical Research?

Quick overview of what patient listening or protocol co-creation in clinical research means.

Thank you for joining Inclusion Criteria: a Clinical Research podcast hosted by me, John Reites. This is an inclusive, non-corporate podcast focused on the people and topics that matter to developing treatments for everyone. It’s my personal project intended to support you in your career, connect with industry experts and contribute to the ideas that advance clinical research.

Inclusion Criteria is the clinical research podcast exploring global clinical trials, drug development, and life‑science innovation. We cover everything clinical research to deepen your industry knowledge, further your career and help you stay current on the market responsible for the future of medicine.

Our episodes discuss current industry headlines, career tips, trending topics, lessons learned, and candid conversations with clinical research experts working to impact our industry everyday.

Watch on YouTube and listen on your favorite podcast app. Thank you for supporting and sharing the show.

Please connect with me (John Reites) at www.linkedin.com/in/johnreites or www.johnreites.com.

The views and opinions expressed by John Reites and guests are provided for informational purposes only. Nothing discussed constitutes medical, legal, regulatory, or financial advice.

Transcript

SPEAKER_00: 0:00

So in today's clinical trials, you're hearing more terminology like patient listening or co-creation with patients. So what does that mean and how does it actually work? We find a representative population of individuals that could potentially meet the inclusion-exclusion criteria of your specific protocol. We then recruit those individuals, consent them, and then we provide them with a series of questions around things like the schedule events, maybe how an endpoint is captured, showing them the informed consent language and educational materials, maybe giving them recruitment ads or recruitment copy that we planned or drafted to use, or showing them the long-term retention strategy for how we believe patients in this clinical trial would want to be supported and engaged longer term. And we take those items, those questions, we make them open-ended, we give them to these participants that are giving of their time and of their effort to support. They respond and give their insights and feedback. And trust me, that insight and feedback is invaluable to a clinical trial's design. You then take those insights, you put them into actions, which means we take what we've learned and we say, hey, if we were to listen to all this feedback, this is the changes we should make in the scheduled events. These are the tweaks we should make in the informed consent. This is the Thank you. or co-creation of a protocol is when you think about designing studies, not just with the patient in mind, but with the patient's feedback and insights as a core part of the actions you take.